Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT

Documenti analoghi

• Early‐Onset Obesity and Tirzepatide Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials
  di: Evgenia Gourgari, et al.
  Pubblicazione: (2025)
• Tirzepatide Associated With Improved Health‐Related Quality of Life in Adults With Obesity or Overweight in SURMOUNT ‐4
  di: Theresa Hunter Gibble, et al.
  Pubblicazione: (2025)
• Association of Tirzepatide With Kidney Parameters in Participants With Obesity and Prediabetes From SURMOUNT ‐1 Over 176 Weeks
  di: Hiddo J. L. Heerspink, et al.
  Pubblicazione: (2026)
• Time to weight plateau with tirzepatide treatment in the SURMOUNT ‐1 and SURMOUNT ‐4 clinical trials
  di: Deborah B. Horn, et al.
  Pubblicazione: (2025)
• Efficacy and Safety of Tirzepatide in Japanese Participants With Obesity: A Subpopulation Analysis of the SURMOUNT ‐1 Trial
  di: Yasushi Ishigaki, et al.
  Pubblicazione: (2026)